Clinical Trial Update: Cervarix Long-term Safety Surveillance

View source ↗

Summary

This clinical trial update reports long-term safety surveillance data for Cervarix, the HPV vaccine, from a completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Human Papillomavirus Infection

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Status: COMPLETED